Search Results 261-270 of 2006 for ❓[광고텔레:TOOPPC] 구글스포츠광고 해외선물DB 통장판매 구글SEO 구글카드깡광고 구글찌라시업체❓
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension. Participation eligibility. Participant ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
After completing all screening assessments and meeting all eligibility criteria, subjects will be randomized to receive placebo or AMG 181 at various doses per ...
The objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug as add-on to standard of care (SOC) therapy for ...
The purposes of this study are to characterize the long-term risk of hepatic failure with TURALIO™, and to evaluate the mechanism of liver injury based upon ...
The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an ...
Warner, M.D., studies patient blood management. Focus areas include clinical and translational research in the space of anemia, coagulopathy, hemorrhage and ...
To evaluate the safety and tolerability of KITE-585, an autologous engineered CAR T-cell product targeting a protein commonly found on myeloma cells called BCMA ...
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
This is a cross-sectional and longitudinal study that will evaluate imaging characteristics of 18F-AV-1451 in cognitively healthy volunteers, mild cognitive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.